Corgi Data & Surveillance ETF
Corgi Data & Surveillance ETF (EYES) Covered Calls
As of October 23, 2026, EYES has 4 covered call opportunities in the coming three months. Return ranges from 4.7 to 8.7% until expiration. Annualized return ranges from 10.5 to 30.1%. The nearest expiration is December 18, 2026. Maximum potential profit is $261.
Read more
Running EYES covered calls helps you generate consistent income from Corgi Data & Surveillance ETF's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Corgi Data & Surveillance ETF involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best EYES covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if EYES stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling EYES covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Corgi Data & Surveillance ETF covered call is worth writing.
On August 30, 2022, Second Sight Medical Products, Inc. underwent a reverse merger, resulting in its acquisition by Nano Precision Medical, Inc. Previously, Second Sight specialized in the creation, production, and commercialization of implantable visual prosthetics, with the goal of restoring artificial vision to individuals who are blind. The company's overarching objective was to advance technologies designed to aid the sight-impaired community. A notable offering was the Orion Visual Cortical Prosthesis System, an implanted cortical stimulator developed to deliver functional artificial vision.
This system targeted individuals suffering from blindness caused by a range of conditions, such as glaucoma, diabetic retinopathy, damage or disease affecting the optic nerve, and other forms of eye injury. Established in 1998, the company was based in Sylmar, California.
Income-focused investors, long-term EYES holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling EYES covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Corgi Data & Surveillance ETF covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryExchange Traded Fund
- SectorFinancial
- IV percentile—
- Market cap (M$)—
- 52 weeks high0.00%
- 52 weeks low27.57%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)—
- EPS growth next 5 years—
As of October 23, 2026
| 2026-12-18 | 57 | 31.00 | 3.20 | 0.45 | 2.55 | 141.00 | 4.69 | 30.06 | -1.50 | +0.47 | 9 | 2.10 |
| 2027-03-19 | 148 | 32.00 | 6.52 | 0.25 | 3.50 | 221.00 | 7.36 | 18.14 | -0.83 | +0.45 | 0 | 3.25 |
| 2027-06-17 | 238 | 32.00 | 6.52 | 0.65 | 4.80 | 261.00 | 8.69 | 13.32 | -2.16 | +0.50 | 0 | 4.15 |
| 2027-06-17 | 238 | 31.00 | 3.20 | 1.10 | 5.30 | 206.00 | 6.86 | 10.52 | -3.66 | +0.55 | 0 | 4.20 |
As of October 23, 2026
Sell covered calls with the data behind you
Find the best EYES covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→